HIMS INVESTOR ALERT: Edelson Lechtzin LLP Urges Hims & Hers Health, Inc. (NYSE: HIMS) Shareholders to Consult an Attorney About the Impending Lead Plaintiff Deadline in the Securities Fraud Class Action
NEWTOWN, Pa., July 6, 2025 /PRNewswire/ — Edelson Lechtzin LLP, a leading class action law firm, is investigating securities fraud claims on behalf of all investors of Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS) who purchased stock pursuant to and/or traceable to Hims & Hers’ statement announcing its long-term partnership with Novo




